Senolytics Human Trials – Intro & Dosing Regimen | Dr James Kirkland Interview Clips
Published September 1, 2022
Views 9.90K | Likes 324 | Comments 12
At a glance
Views
9,903
Likes
324
Comments
12
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
Dr James Kirkland talks about among many senolytics why they chose quercetin, dastatinib and fisetin for trials and what is the target and dosing regimen of a couple of human trials in this clip. https://link.springer.com/article/10.14283/jpad.2021.62 Senolytic Therapy to Modulate the Progression of Alzheimer’s Diseas…
- Published
- September 1, 2022
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.